VENTRIA BIOSCIENCE
Recombinant human lactoferrin (rhLF) produced in rice for inflammatory bowel disease treatment
- Sector
- Biotech
- Total capital
- $613K
- Federal grants
- $308K
- 1 award · 2014
- Rank in peer group#468 of 502
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $305K
- 3 awards · Health and Human S
- Rank in Biotech#260 of 4373
- Granted patents
- 3
- 25 pending · first 2020
- Rank in peer group#28 of 502
Capital timeline
Latest events
- Federal contractHealth and Human S · Rtv Bait$150K
- Federal grantHealth and Human S · Phase I · Oral rice-derived lactoferrin reduced the severity of Crohn's disease through anti-inflammatory regulation of T cells$308K
- Federal contractHealth and Human S · M-27496 00HCVHCC-2008-59514 - Vetria Rice Lyme Disease Tests$80K
- Federal contractHealth and Human S · 000HCRT4-2006-32853 - Bzb Expression Services$75K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#28 · top 6%
- Linked publications#16 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 3 granted of 28- GrantedCell Culture Media Containing Combinations Of ProteinsUSPTOUS 11,492,389
- GrantedCell Culture Media Containing Combinations Of ProteinsUSPTOUS 10,981,974
- GrantedCell Culture Media Containing Combinations Of ProteinsUSPTOUS 10,618,951
Show all 28 patent records
- Cell Culture Media Containing Combinations Of ProteinsNov 8, 2022 · US 11,492,389Granted
- Cell Culture Media Containing Combinations Of ProteinsApr 20, 2021 · US 10,981,974Granted
- Cell Culture Media Containing Combinations Of ProteinsApr 14, 2020 · US 10,618,951Granted
- Lactoferrin Compositions And Methods For Modulation Of T Cell Subtypes And Treatment Of Autoimmune DiseasesSep 6, 2018 · Application 15758537Pending
- OspA Fusion Protein for Vaccination against Lyme DiseaseJul 28, 2016 · Application 15024036Pending
- Non-glycosylated Transferrin Expressed In MonocotsMar 17, 2016 · Application 14668955Pending
- Lactoferrin Compositions And Methods For Modulation Of T Cell Subtypes And Treatment Of Autoimmune DiseasesApplication PCTUS2016051384Pending
- Lactoferrin Compositions And Methods For Modulation Of T Cell Subtypes And Treatment Of Autoimmune DiseasesApplication 62217782Pending
- Ospa Fusion Protein For Vaccination Against Lyme DiseaseApplication PCTUS2014000191Pending
- Methods & Compositions For Improving Protein ProductionApplication PCTUS2011022229Pending
- Methods & Compositions Comprising Heat Shock ProteinsApplication PCTUS2010061126Pending
- Cell Culture Media Containing Combinations Of ProteinsApplication PCTUS2010024626Pending
- Production Of Ospa For Lyme Disease ControlApplication PCTUS2009040083Pending
- Compositions Containing Lactoferrin And Calcium, And Methods Of Using SameApplication PCTUS2008001073Pending
- Compositions Containing Lactoferring, And Methods Of Using Same To Promote Growth Of Skin CellsApplication PCTUS2007004388Pending
- Production Of Human Defensins In Plant CellsApplication PCTUS2006047606Pending
- Oral Formulation For Enteric Disorders And/or RehydrationApplication PCTUS2006037720Pending
- Components Of Cell Culture Media Produced From Plant CellsApplication PCTUS2006025195Pending
- High-level Expression Of Fusion Polypeptides In Plant Seeds Utilizing Seed-storage Proteins As Fusion CarriersApplication PCTUS2004041083Pending
- Expression Of Human Milk Protein In Transgenic PlantsApplication PCTUS2004026230Pending
- Methods Of Expressing Heterologous Protein In Plant Seeds Using Monocot Non Seed-storage Protein PromotersApplication PCTUS2003039107Pending
- Lactoferrin Protein With Iron For Treating Deficiency And AnemiaApplication PCTUS2002040731Pending
- Expression System For Seed ProteinsApplication PCTUS2002004909Pending
- Enhanced Expression Yield Of Immunoglobulin A In EukaryotesApplication PCTUS2021020437Pending
- Enhanced Expression Yield Of Immunoglobulin A In EukaryotesApplication 62984162Pending
- Formulations Of Immunoglobulin AApplication PCTUS2019049709Pending
- Oral Formulations Of Immunoglobulin AApplication 62780544Pending
- Stable Formulations Of Immunoglobulin AApplication 62727345Pending
Recent research by its founders
- VEN-120, a Recombinant Human Lactoferrin, Promotes a Regulatory T Cell [Treg] Phenotype and Drives Resolution of Inflammation in Distinct Murine Models of Inflammatory Bowel Disease201741 cites
- IFN-γ–Mediated Induction of an Apical IL-10 Receptor on Polarized Intestinal Epithelia201398 cites
- HIF‐dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function201322 cites
Related companies, and why
- Beta Hatch Inc.Similar federal contract value in Biotech · $324K in contracts
- Celltheon CorpSimilar federal contract value in Biotech · $322K in contracts
- FOX CHASE CHEMICAL DIVERSITY CENTER INC.Similar federal contract value in Biotech · $307K in contracts
- MIRECULE INCSimilar federal contract value in Biotech · $305K in contracts
- AMYRIS, INC.Similar federal contract value in Biotech · $303K in contracts
- Oncotab, Inc.Similar federal contract value in Biotech · $300K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .